🇮🇳 India Daybook: Sun Pharma Inks Massive $11.75B Deal; Adani Power & Bajaj Finance Eye Q4 Results

📍 EARNINGS TODAY

• Adani Power: The company is set to report its Q4 and full-year FY26 results today. Investors are watching for operational updates following the stock's recent record-high performance.
• Bajaj Finance: Along with Q4 results, the board will consider a dividend recommendation and a significant new fundraising proposal.
• Vedanta: The mining major will release its quarterly performance report, with a focus on debt reduction and production volumes.
• Other Key Results: Waaree Energies, Federal Bank, Indian Bank, Indian Overseas Bank, Mphasis, Motilal Oswal, Granules India, KFin Technologies, and Navin Fluorine.

📍 ACQUISITION

• Sun Pharmaceutical Industries: Announced a definitive agreement to acquire New Jersey-based Organon for $11.75 billion. This marks the largest-ever overseas acquisition by an Indian pharmaceutical company, aimed at strengthening its global specialty portfolio.
• Gujarat Themis Biosyn: Completed the acquisition of Sanofi’s tuberculosis drug portfolio, a strategic move to bolster its presence in the anti-infectives segment.

📍 ORDER WIN

• Rail Vikas Nigam Limited (RVNL): Secured a construction contract worth ₹39 crore from NMDC for infrastructure development.
• SEAMEC: Alongside Supreme Hydro, the company signed an Operations and Maintenance (O&M) contract with ONGC for the vessel 'Samudra Sevak,' valid through 2028.
• PC Jeweller: Its subsidiary, PCJ Mining, has been granted a one-year gold-mining license in Chad, marking a diversification into the mining sector.

📍 REGULATORY APPROVAL / USFDA

• Cipla: Received final USFDA approval for its generic version of Ventolin (albuterol inhaler) and Nintedanib capsules. Analysts estimate these products could generate over $100 million in annual sales.
• Alembic Pharmaceuticals: Granted final USFDA approval for Fingolimod capsules (0.5 mg), used for Multiple Sclerosis. This represents the company’s 237th ANDA approval to date.
• Solara Active Pharma Sciences: The USFDA concluded an inspection at its Puducherry facility, classifying it as Voluntary Action Indicated (VAI).

📍 FUNDRAISING / CORPORATE ACTION

• Adani Power: Formally signaled its entry into the nuclear energy sector by incorporating two new subsidiaries: Adani Atomic Energy Ltd. and Rawatbhata-Raj Atomic Energy Ltd.
• Quess Corp: Confirmed the receipt of an income-tax refund amounting to ₹42.24 crore for the financial year 2023-24.
• Kiri Industries: Its subsidiary, Equinaire, executed a loan assignment agreement to acquire a $9.76 million mining-project loan for a copper-gold project in the Philippines.

TAGS: India Daybook, Stocks in News, Corporate News, Stock Market, Company News

Tags: India Daybook Stocks in News Corporate News Stock Market Company News